Clinical trial
Open access
Aug 2026
Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study
This study supports the safety profile of MenACYW-TT in infants and toddlers aged ≥ 6 weeks and overall well tolerated, and safety profiles were comparable.
Abraham Moskow, Sandeep Gupta, M. Dhingra et al.
· Human Vaccines & Immunothera... · 0 citations